triple-negative breast cancer
Conditions
Brief summary
Results of post-operative histopathological examination and immunohistochemical analysis assessing PSMA expression.
Detailed description
The incidence of Adverse Events of grade ≥3 severity (according to CTCAE toxicity grading) and the incidence of Serious Adverse Events, in relation to [99mTc]Tc-PSMA-T4 uptake., Results of genetic testing based on liquid biopsy and their correlation with the degree of [99mTc]Tc-PSMA-T4 uptake., Results of immunohistochemical analysis of PSMA receptor expression in histopathological samples., Results of triple-negative breast cancer (TNBC) molecular subtypes.
Interventions
Sponsors
Narodowe Centrum Badan Jadrowych
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Results of post-operative histopathological examination and immunohistochemical analysis assessing PSMA expression. | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of Adverse Events of grade ≥3 severity (according to CTCAE toxicity grading) and the incidence of Serious Adverse Events, in relation to [99mTc]Tc-PSMA-T4 uptake., Results of genetic testing based on liquid biopsy and their correlation with the degree of [99mTc]Tc-PSMA-T4 uptake., Results of immunohistochemical analysis of PSMA receptor expression in histopathological samples., Results of triple-negative breast cancer (TNBC) molecular subtypes. | — |
Outcome results
None listed